Anacor Pharmaceuticals Reports 2015 Fourth Quarter and Year-End Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Anacor Pharmaceuticals Reports 2015 Fourth Quarter and Year-End Financial Results

Jefferies Cuts Price Target on Anacor Pharma (ANAC) to $105 Following a 4Q EPS Miss

March 1, 2016 9:12 AM EST

Jefferies maintained a Buy rating on Anacor Pharmaceuticals (NASDAQ: ANAC), and cut the price target to $105.00 (from $159.00), following the company's 4Q earnings report. ANAC reported an EPS loss of $0.43, missing Jefferies' estimates for a loss of $0.31. Management attributed the miss to short term competitive... More

Anacor Pharma (ANAC) Misses Q4 EPS by 13c

February 29, 2016 4:04 PM EST

Anacor Pharma (NASDAQ: ANAC) reported Q4 EPS of ($0.43), $0.13 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $21.2 million versus the consensus estimate of $27.93 million.

For earnings history and earnings-related data on Anacor Pharma (ANAC) click here.

... More